Kevin M. Rigby

Kevin M. Rigby has extensive work experience in the field of biopharmaceuticals and molecular medicine. Kevin M. started their career as a Post-doctoral Fellow at the National Institutes of Health in 2008, where they worked until 2012. Following this, they joined the University of Utah School of Medicine as a Research Scientist in Molecular Medicine, from 2012 to 2014. Kevin M. then transitioned to miRagen Therapeutics, Inc. as a Senior Research Scientist, where they worked from 2014 to 2019. Currently, Kevin M. Rigby holds the position of Principal Scientist at KBI Biopharma since April 2020.

Kevin M. Rigby completed their Bachelor of Science degree in Chemistry with a Biological emphasis at the University of Montana from 1997 to 2002. Kevin M. further pursued their education at the University of Utah School of Medicine, earning a Doctor of Philosophy degree in Biochemistry from 2002 to 2007.